Scandium Canada Ltée (TSXV: SCD) has appointed Noel Dubé, ing. phys., to its board of directors and as strategic adviser to its wholly owned commercialisation subsidiary, Scalium+, effective 21 September 2026. The appointment is aimed at accelerating the commercialisation of aluminium-scandium alloys and specialised Scalium® surface treatments. Dubé brings more than 20 years of technical and executive experience in the technology sector and has been a long-standing shareholder and strategic adviser to the company since 2024. Investors may be watching this governance addition as SCD advances its dual-engine strategy across both Scalium+ and the Crater Lake mining project.

Key Points

  • Scandium Canada Ltée (TSXV: SCD) announced the board appointment of Noel Dubé, ing. phys., effective 21 September 2026
  • Dubé will also serve as strategic adviser to Scalium+, SCD's aluminium-scandium alloy commercialisation subsidiary
  • 500,000 stock options granted at an exercise price of $0.22, vesting monthly over 36 months, expiring 21 September 2031, subject to TSX Venture Exchange final approval
  • Investors may watch for progress on Scalium+ customer acquisition and advancement of the Crater Lake project in Nunavik, Québec

Dubé's Background in High-Technology Commercialisation

Noel Dubé holds a degree in engineering physics and has spent more than 20 years in technology leadership. He served as President and Chief Executive Officer of Reflex Photonics from October 2013 to November 2019. Earlier, he was a co-founder, Vice-President of Sales and Business Development, and board member of R/D Tech inc., a research and development firm that grew revenues from $2 million CAD to $180 million CAD, employed 600 people, and operated 12 offices across more than 50 countries. The release states he is also an active investor in Québec technology funds and has provided technical and strategic advisory services to multiple companies.

Role Within Scalium+ and the Al-Sc Commercialisation Strategy

Scalium+, formerly Ferreol Technologies, is SCD's wholly owned subsidiary dedicated to bringing aluminium-scandium alloys and the Scalium® product line to market across multiple industrial sectors. The disclosure suggests Dubé's appointment is specifically intended to bridge the gap between laboratory-validated technology and international revenue generation. Board chair Jeff Swinoga noted in the release that Dubé has been engaged as a strategic adviser since 2024 and brings direct experience scaling technology businesses and commercialising highly technical products internationally — capabilities the company considers directly relevant to Scalium+'s current growth phase.

Stock Option Grant and Regulatory Conditions

In connection with the appointment, Scandium Canada has granted Dubé 500,000 stock options under its existing stock option plan. Each option entitles the holder to acquire one common share at an exercise price of $0.22 for a five-year term ending 21 September 2031. Vesting proceeds at approximately 1/36 per month, commencing from the last day of the month following the grant date. The company stated that the grant remains subject to final approval from the TSX Venture Exchange. The immediate share price impact was not clear from available public information.